<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23669" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Intestinal Pseudo-Obstruction</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmed</surname>
            <given-names>Saif</given-names>
          </name>
          <aff>Henry Ford Wyandotte Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharman</surname>
            <given-names>Tariq</given-names>
          </name>
          <aff>Southern Ohio Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Saif Ahmed declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Tariq Sharman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23669.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Intestinal pseudo-obstruction is characterized by the dilation of bowel in the absence of an anatomical obstruction. Patients present with the signs and symptoms of a bowel obstruction including nausea, vomiting, abdominal distension, and obstipation with bowel dilation on x-ray or CT imaging. This activity reviews the role of the interprofessional team in the evaluation and management of intestinal pseudo-obstruction and explains the medical, endoscopic, and surgical options for treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Explain the common physical exam findings associated with intestinal pseudo-obstruction.</p></list-item><list-item><p>Describe the typical imaging findings associated with intestinal pseudo-obstruction.</p></list-item><list-item><p>Outline the management options available for intestinal pseudo-obstruction.</p></list-item><list-item><p>Review the importance of improving care coordination amongst interprofessional team members to improve outcomes for patients affected by intestinal pseudo-obstruction.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23669&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23669">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23669.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Intestinal pseudo-obstruction is characterized by the dilation of bowel in the absence of an anatomical&#x000a0;obstruction. Patients present with the signs and symptoms of bowel obstruction, including nausea, vomiting, abdominal distension, and obstipation with bowel dilation on x-ray or CT imaging. Pseudo-obstruction can be acute or chronic. Acute colonic pseudo-obstruction (ACPO), also known as Ogilvie syndrome, most commonly affects the large intestine from the cecum to the splenic flexure. The exact pathophysiology is unknown, but it has been linked to dysregulation of the autonomic nervous system.&#x000a0;Most cases are found in patients who have undergone surgery or are critically ill. After a mechanical obstruction is ruled out, initial management includes&#x000a0;bowel rest, nasogastric decompression, intravenous fluid resuscitation, and treatment of the underlying cause.</p>
        <p>Further&#x000a0;treatment options include administration of Neostigmine as well as endoscopic, percutaneous, or surgical decompression. Chronic intestinal pseudo-obstruction (CIPO) is a more rare form of pseudo-obstruction, usually causing early satiety, nausea, bloating, and distension.&#x000a0; Causes&#x000a0;are usually infectious, metabolic, neurologic, autoimmune, or idiopathic.</p>
      </sec>
      <sec id="article-23669.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Although the exact cause of acute intestinal pseudo-obstruction is unknown, current theories suggest that the inhibition of parasympathetic activity, dysregulation of stretch receptors, and decreased ganglion cells in the colonic smooth muscle play an important role.&#x000a0;Specifically, decreased parasympathetic activity, which plays an excitatory role for colonic motility, from the sacral plexus is thought to play a role in colonic atony.<xref ref-type="bibr" rid="article-23669.r1">[1]</xref>&#x000a0;Other possible contributors to intestinal pseudo-obstruction include decreased splanchnic perfusion, anticholinergic medications, opiates, hypokalemia, and uremia.<xref ref-type="bibr" rid="article-23669.r2">[2]</xref></p>
        <p>The pathophysiology of chronic intestinal pseudo-obstruction (CIPO) is better understood with multiple causes identified. Neuropathies, myopathies, or abnormalities of the interstitial cells of Cajal have all been attributed to CIPO.<xref ref-type="bibr" rid="article-23669.r3">[3]</xref><xref ref-type="bibr" rid="article-23669.r4">[4]</xref>&#x000a0;Known diseases that compromise the neuromuscular pathway include Hirschsprung disease, Parkinson disease, scleroderma, diabetes, Ehlers-Danlos syndrome, Fabry disease, and Chagas disease.&#x000a0;Most cases are sporadic; however, rare genetic causes have been also associated with CIPO.&#x000a0; Additionally, paraneoplastic syndromes from small cell lung cancers, carcinoid tumors, and thymomas have been associated with CIPO due to&#x000a0;an antineuronal nuclear antibody (anti-Hu) that possibly shares an epitope with the enteric nervous system causing inflammation and infiltration.<xref ref-type="bibr" rid="article-23669.r5">[5]</xref></p>
      </sec>
      <sec id="article-23669.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Acute intestinal&#x000a0;pseudo-obstruction is more common in men and patients over the ages of 60. The annual incidence is estimated to be around 100/100,000 for every inpatient admission.<xref ref-type="bibr" rid="article-23669.r6">[6]</xref> Cases are typically found in hospitalized patients after surgery or after a severe illness. Medications, metabolic imbalances, non-operative trauma, surgery, and cardiac disease have all been associated with intestinal pseudo-obstruction.<xref ref-type="bibr" rid="article-23669.r1">[1]</xref> CIPO can develop in children and adults.<xref ref-type="bibr" rid="article-23669.r4">[4]</xref> Many patients with CIPO also have underlying degenerative neuropathic and myopathic conditions. It is estimated that 20% of patients on home parenteral nutrition have CIPO.&#x000a0;Limited epidemiological studies characterized CIPO in the U.S.&#x000a0;Studies from Japan have reported a prevalence of 0.8 and 1.0 and an incidence of 0.21 and 0.24 cases per 100,000 adult men and women, respectively.<xref ref-type="bibr" rid="article-23669.r7">[7]</xref></p>
      </sec>
      <sec id="article-23669.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The exact mechanism of acute intestinal pseudo-obstruction is still unknown. However, the relationship between trauma, spinal anesthesia, and certain medications suggests a possible impairment of the&#x000a0;autonomic&#x000a0;nervous system.<xref ref-type="bibr" rid="article-23669.r1">[1]</xref> All of the proposed mechanisms describe the pathogenesis of a lack of colonic motility.<xref ref-type="bibr" rid="article-23669.r8">[8]</xref> The major concern for intestinal pseudo-obstruction is bowel dilatation, which can lead to ischemia and perforation.&#x000a0;The cecum, because of its larger diameter compared to the rest of the bowel, requires the least amount of pressure to distend as described in the law of Laplace.&#x000a0;Under normal circumstances, the cecal diameter is less than 9 cm. The risk for ischemia and perforation increases after 10 cm with impending perforation when the diameter is greater than 12 cm for longer than six days.<xref ref-type="bibr" rid="article-23669.r9">[9]</xref> It is not only the diameter and the duration of distension that increase the risk of perforation but the acceleration&#x000a0;of the distension.</p>
        <p>Chronic intestinal pseudo-obstruction has been associated with a myriad of diseases. Neuropathies&#x000a0;such as Parkinson disease and diabetes mellitus have been implicated in the degeneration of the signaling pathway of the enteric nervous system causing CIPO.<xref ref-type="bibr" rid="article-23669.r10">[10]</xref>&#x000a0;Scleroderma, lupus, and&#x000a0;paraneoplastic syndromes&#x000a0;have been associated with immune-mediated CIPO damaging the enteric nerves and smooth muscle cells of the gastrointestinal tract.<xref ref-type="bibr" rid="article-23669.r10">[10]</xref>&#x000a0;The most common infectious etiology is Chagas disease, where inflammatory changes of the enteric neural pathways to the gastrointestinal tract are altered.<xref ref-type="bibr" rid="article-23669.r11">[11]</xref> There are many genetic&#x000a0;disorders (e.g., Fabry disease, Ehler Danlos Syndrome, Hirschsprung disease)&#x000a0;under investigation for their involvement in CIPO.<xref ref-type="bibr" rid="article-23669.r4">[4]</xref></p>
      </sec>
      <sec id="article-23669.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Abdominal distension is the&#x000a0;key clinical feature in intestinal pseudo-obstruction occurring in about 80% of cases.<xref ref-type="bibr" rid="article-23669.r1">[1]</xref> Nausea, vomiting, early satiety, constipation, and generalized abdominal pain&#x000a0;can also be observed.<xref ref-type="bibr" rid="article-23669.r12">[12]</xref> These symptoms can be acute, chronic, or recurrent.&#x000a0;Patients may also exhibit symptoms from a neuromuscular disease that is associated with&#x000a0;CIPO.</p>
        <p>In ACPO, patients are typically already hospitalized&#x000a0;with a severe illness or after surgery.<xref ref-type="bibr" rid="article-23669.r13">[13]</xref> The findings of abdominal distension can occur rapidly or after several days.&#x000a0;Patients presenting with fever, severe abdominal tenderness, or peritonitis may have progressed to bowel ischemia or perforation from the increased distension.</p>
      </sec>
      <sec id="article-23669.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The key feature of intestinal pseudo-obstruction is abdominal distension.&#x000a0;As the differential for a distended abdomen is broad, imaging is useful in establishing a diagnosis. X-rays of the abdomen will demonstrate air-fluid levels with dilated loops of bowel.&#x000a0;The pathognomonic finding for ACPO is a dilated colon from the cecum to the splenic flexure or even the rectum.&#x000a0;Findings of a dilated colon are nonspecific, and thus further investigation beyond x-ray is required to confirm the diagnosis.</p>
        <p>Abdominal CT scans are much more specific than abdominal x-rays.&#x000a0;CT will also demonstrate dilated loops of bowel, air-fluid levels, or specifically proximal colonic dilatation from the cecum to the splenic flexure or even the rectum.&#x000a0;No mechanical obstruction must be identified, such as closed-loop obstructions, hernias, strictures, or masses.&#x000a0;In the acute setting, contrast enemas and small bowel follow-throughs can be essential adjuncts to rule out these obstructions.</p>
        <p>Although no specific labs will suggest intestinal pseudo-obstruction, a liver profile and lipase should be obtained to rule out other causes of abdominal pain.&#x000a0;A&#x000a0;complete blood count&#x000a0;and serum&#x000a0;lactate should also be obtained as leukocytosis, and elevated serum lactate can be increased in cases of bowel ischemia and perforation. In patients with chronic symptoms, vitamin B12, folate, TSH, and celiac serology should be ordered to assess for metabolic and autoimmune abnormalities.&#x000a0;Additionally, serologic testing for herpes simplex virus, cytomegalovirus, and Epstein-Barr virus can assist in the diagnosis as viruses may cause&#x000a0;inflammation&#x000a0;of the enteric nervous system causing CIPO.&#x000a0; Finally, antineuronal antibodies (ANNA-1/anti-Hu)&#x000a0;can also be analyzed to assess for paraneoplastic immune-mediated pseudo-obstruction.<xref ref-type="bibr" rid="article-23669.r12">[12]</xref></p>
        <p>Patients with a dilated colon and rectum raise suspicion for toxic megacolon. Stool cultures and stool evaluation for <italic toggle="yes">Clostridioides&#x000a0;difficile&#x000a0;</italic>toxin should be obtained, especially in patients with diarrhea. As metabolic abnormalities, including hypokalemia, hypomagnesemia, and hypocalcemia, have been associated with intestinal pseudo-obstruction, a metabolic panel should be obtained so that these may be repleted.</p>
        <p>Patients with chronic symptoms may undergo further testing to identify the cause of symptoms. An upper endoscopy and colonoscopy should be performed to identify and locate any pathology or areas of obstruction. If an endoscopy demonstrates no abnormalities, scintigraphy, which assesses the motility of the gastrointestinal tract, may be employed. With scintigraphy, patients ingest resin pellets and undergo a series of imaging to assess the transit time.&#x000a0;If an abnormality is seen on scintigraphy, a manometry study of the esophagus, stomach, and small intestine can delineate an underlying diagnosis and differentiate between myopathic and neuropathic disorders based on the pattern and amplitude of contraction.</p>
        <p>As many neurological disorders are known to cause gastrointestinal dysmotility, autonomic function testing can differentiate peripheral neuropathy from central lesions.<xref ref-type="bibr" rid="article-23669.r5">[5]</xref> In patients with severe dysmotility and known diagnosis, a full-thickness biopsy can be used to identify abnormalities in the enteric nervous system.</p>
      </sec>
      <sec id="article-23669.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of ACPO involves decompression of the dilated colon to prevent bowel ischemia and perforation. Initial management in a stable patient may be conservative with serial x-rays of the abdomen to evaluate colonic diameter.<xref ref-type="bibr" rid="article-23669.r14">[14]</xref> During this time, underlying causes should be treated and corrected.&#x000a0; These causes include electrolyte abnormalities, infections, and medication side effects (e.g., anticholinergics and opiates). A nasogastric tube connected to intermittent suction can be placed to assist in decompression and prevent aspiration.&#x000a0;A rectal tube to dependent drainage can also be placed to assist in decompression. If no improvement is seen after 48-72 hours, neostigmine may be administered.<xref ref-type="bibr" rid="article-23669.r14">[14]</xref></p>
        <p>Neostigmine is an acetylcholinesterase inhibitor that exhibits a parasympathomimetic effect by increasing the amount of available acetylcholine and indirectly stimulating muscarinic and nicotinic receptors.&#x000a0; These receptors, which are located on the smooth muscle of bowel mucosa,&#x000a0;cause muscle contraction.&#x000a0;The initial dose is 2 mg, administered slowly over 5 minutes.<xref ref-type="bibr" rid="article-23669.r15">[15]</xref> Due to the side effect of bradycardia from neostigmine,&#x000a0;patients should be placed in a monitored bed with telemetry and with atropine available at the bedside.&#x000a0;A reduced dose should be&#x000a0;used in patients with a history of heart block.</p>
        <p>If the pharmacologic approach is unsuccessful or contraindicated, colonoscopic decompression should be considered. The colonoscope is advanced to the dilated bowel, and the air is suctioned.&#x000a0;A decompression tube can also be placed up to the transverse colon with the aid of a guidewire to prevent re-occurrence.<xref ref-type="bibr" rid="article-23669.r13">[13]</xref></p>
        <p>Surgery remains the final option when the above measures have failed or if the patient's condition continues to worsen. Options include placing a cecostomy tube or performing a colectomy.<xref ref-type="bibr" rid="article-23669.r16">[16]</xref> A cecostomy involves placing a tube in the cecum which can drain and decompress outside of the abdomen.&#x000a0;Alternatively, the dilated portion of the bowel can be resected with primary anastomosis or an ostomy.&#x000a0;Any patient who develops peritonitis or becomes hemodynamically unstable presumably from bowel ischemia or perforation requires surgical evaluation and resection of the compromised bowel.</p>
        <p>For patients with chronic symptoms, prokinetic agents can help treat oral intake intolerance. Erythromycin is useful in treating acute exacerbations by stimulating motilin receptors in the bowel.<xref ref-type="bibr" rid="article-23669.r17">[17]</xref> This is useful in the hospitalized setting but has not been shown to be effective for long-term treatment.<xref ref-type="bibr" rid="article-23669.r18">[18]</xref> For patients that cannot tolerate erythromycin, metoclopramide has proven to be effective.&#x000a0;However, like erythromycin, it has not been proven effective for long-term treatment.&#x000a0;Prucalopride and cisapride are prokinetic agents currently being investigated to improve gastric emptying and symptomatic relief.<xref ref-type="bibr" rid="article-23669.r19">[19]</xref><xref ref-type="bibr" rid="article-23669.r20">[20]</xref></p>
        <p>Proper nutritional assessment is also imperative for patients with CIPO.&#x000a0; Patients with oral intake intolerance should employ strategies such as small, frequent meals, and high-calorie drinks. If these adjuncts are unsuccessful in achieving caloric goals, feeding tube access through a gastrostomy tube. A jejunostomy may be indicated if there is evidence of gastroparesis in conjunction with CIPO.&#x000a0; Finally, patients with severe symptoms may require parenteral nutrition.</p>
      </sec>
      <sec id="article-23669.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
<bold>Mechanical Obstructions</bold>
</p>
        <p>Mechanical obstructions will present as dilation of bowel proximal to the obstructed point.&#x000a0;Mechanical obstructions include incarcerated hernia, stricture, volvulus, or mass. Typically a "transition point" will be observed where proximal bowel is dilated and distal bowel compressed.&#x000a0;If contrast is administered either by mouth or by enema, a cut-off may be seen.</p>
        <p>
<bold>Toxic Megacolon</bold>
</p>
        <p>In addition to abdominal distension on physical exam and abdominal radiograph, patients with toxic megacolon typically exhibit systemic inflammatory response syndrome (SIRS) criteria including fever, tachycardia, tachypnea, and altered mental status. The patients also more commonly have abdominal pain and bloody diarrhea. Toxic megacolon is commonly seen with ulcerative colitis but may also be seen with other types of colitis, e.g., ischemic, infectious, pseudomembranous. Clinical deterioration requires surgical evaluation for total colectomy with end ileostomy.&#x000a0;</p>
        <p>
<bold>Fecal Impaction</bold>
</p>
        <p>A dilated rectum and colon is commonly seen with fecal impaction.&#x000a0;Patients with these findings should have a digital rectal exam to rule out impacted stool.&#x000a0;Additionally, fecal matter can be seen on radiograph and CT imaging.&#x000a0;Once the impaction is resolved, patients typically have a resolution of their symptoms.</p>
      </sec>
      <sec id="article-23669.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The mortality rate for adult patients with CIPO is approximately 10%.&#x000a0;One-third of patients with CIPO will require parenteral nutrition with its associated complications, which are estimated between 45% to 80%.<xref ref-type="bibr" rid="article-23669.r21">[21]</xref></p>
        <p>In children, mortality rates range from 10% to 40%, with parenteral nutrition dependence as high as 60% to 80%.<xref ref-type="bibr" rid="article-23669.r22">[22]</xref></p>
        <p>In ACPO, the prognosis is predicated on the development of bowel ischemia or perforation, which&#x000a0;occurs in 3% to 15% of cases.&#x000a0;The mortality rate with ischemic bowel or perforation is 40%&#x000a0;versus 15% without perforation.<xref ref-type="bibr" rid="article-23669.r23">[23]</xref><xref ref-type="bibr" rid="article-23669.r24">[24]</xref></p>
      </sec>
      <sec id="article-23669.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Failure to address the colonic distension for intestinal pseudo-obstruction can result in the major complications of&#x000a0;bowel ischemia or perforation, which may require urgent surgical intervention.&#x000a0;As discussed previously, if a mechanical obstruction is not ruled out, the administration of neostigmine in a patient with a bowel obstruction can result in a catastrophic perforation.</p>
      </sec>
      <sec id="article-23669.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Intestinal pseudo-obstruction is a relatively uncommon condition with broad and vague symptoms.&#x000a0;Patients with chronic symptoms of unexplained abdominal distension and nausea should seek consultation with a gastroenterologist.&#x000a0;Lifestyle modifications, nutritional assessment, and endoscopic interventions may be employed to rule out common etiologies for symptoms before further workup of intestinal pseudo-obstruction is initiated.</p>
        <p>For acute and severe episodes of abdominal distension and oral intake intolerance, patients should report to the emergency room.&#x000a0;Surgical emergencies (i.e., appendicitis, bowel obstruction, incarcerated hernias) must be ruled out before initiating the management of intestinal pseudo-obstruction.</p>
      </sec>
      <sec id="article-23669.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Intestinal pseudo-obstruction is a disorder with unclear etiology and non-specific signs and symptoms, including abdominal distension, nausea, and vomiting.&#x000a0;As this condition typically arises in patients who are critically ill or have had previous surgery, there may be a need for gastroenterologist or surgeon to be on the case.&#x000a0;If abdominal imaging is obtained, the case should be discussed with a radiologist if bowel diameter or obstruction is not assessed. If patients fail to progress with supportive care, neostigmine may be used.&#x000a0;The administration of neostigmine requires continuous cardiac telemetry, which may require admission to an intensive care unit or cardiac care unit.</p>
        <p>Nurses play an important role in actively monitoring the vitals, specifically assessing for bradycardia.&#x000a0;In these scenarios, specific instructions need to be relayed for atropine administration.&#x000a0;The pharmacist&#x000a0;can&#x000a0;ensure that proper dosage is provided as well as ensure that there are no drug-drug interactions.&#x000a0; If&#x000a0;neostigmine&#x000a0;is unsuccessful, endoscopic decompression can be attempted by a gastroenterologist, general surgeon, or colorectal surgeon. If endoscopic decompression is still unsuccessful, then surgery is indicated either for colectomy or cecostomy. In specific situations for high-risk surgeries or those unfit for surgery, interventional radiology may be consulted for a percutaneous cecostomy.&#x000a0;</p>
        <p>The above practice guideline is consistent with the Clinical Practice Guideline from the American Society of Colon and Rectal Surgeons and the American Society for Gastrointestinal Endoscopy. [Level 2]</p>
      </sec>
      <sec id="article-23669.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23669&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23669">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/gut-health/intestinal-pseudo-obstruction/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23669">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23669/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23669">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23669.s15">
        <title>References</title>
        <ref id="article-23669.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vanek</surname>
                <given-names>VW</given-names>
              </name>
              <name>
                <surname>Al-Salti</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Acute pseudo-obstruction of the colon (Ogilvie's syndrome). An analysis of 400 cases.</article-title>
            <source>Dis Colon Rectum</source>
            <year>1986</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>203</fpage>
            <page-range>203-10</page-range>
            <pub-id pub-id-type="pmid">3753674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wells</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>O'Grady</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bissett</surname>
                <given-names>IP</given-names>
              </name>
            </person-group>
            <article-title>Acute colonic pseudo-obstruction: A systematic review of aetiology and mechanisms.</article-title>
            <source>World J Gastroenterol</source>
            <year>2017</year>
            <month>Aug</month>
            <day>14</day>
            <volume>23</volume>
            <issue>30</issue>
            <fpage>5634</fpage>
            <page-range>5634-5644</page-range>
            <pub-id pub-id-type="pmid">28852322</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gallego</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Malagelada</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Accarino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gori</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Malagelada</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Azpiroz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>De Giorgio</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jimenez</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Functional neuromuscular impairment in severe intestinal dysmotility.</article-title>
            <source>Neurogastroenterol Motil</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>30</volume>
            <issue>12</issue>
            <fpage>e13458</fpage>
            <pub-id pub-id-type="pmid">30178519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Egal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jou&#x000eb;t</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lamarque</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>[Chronic intestinal pseudo-obstruction in adults].</article-title>
            <source>Rev Med Interne</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>39</volume>
            <issue>10</issue>
            <fpage>792</fpage>
            <page-range>792-799</page-range>
            <pub-id pub-id-type="pmid">29937298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lennon</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Sas</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Busk</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Scheithauer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Malagelada</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Camilleri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma.</article-title>
            <source>Gastroenterology</source>
            <year>1991</year>
            <month>Jan</month>
            <volume>100</volume>
            <issue>1</issue>
            <fpage>137</fpage>
            <page-range>137-42</page-range>
            <pub-id pub-id-type="pmid">1845756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ross</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Oommen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wormer</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Walters</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Augenstein</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Heniford</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Sing</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Christmas</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Acute Colonic Pseudo-obstruction: Defining the Epidemiology, Treatment, and Adverse Outcomes of Ogilvie's Syndrome.</article-title>
            <source>Am Surg</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>82</volume>
            <issue>2</issue>
            <fpage>102</fpage>
            <page-range>102-11</page-range>
            <pub-id pub-id-type="pmid">26874130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iida</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ohkubo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Inamori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakajima</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and clinical experience of chronic intestinal pseudo-obstruction in Japan: a nationwide epidemiologic survey.</article-title>
            <source>J Epidemiol</source>
            <year>2013</year>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>288</fpage>
            <page-range>288-94</page-range>
            <pub-id pub-id-type="pmid">23831693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ogilvie</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>William Heneage Ogilvie 1887-1971. Large-intestine colic due to sympathetic deprivation. A new clinical syndrome.</article-title>
            <source>Dis Colon Rectum</source>
            <year>1987</year>
            <month>Dec</month>
            <volume>30</volume>
            <issue>12</issue>
            <fpage>984</fpage>
            <page-range>984-7</page-range>
            <pub-id pub-id-type="pmid">3319452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saunders</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Acute colonic pseudo-obstruction.</article-title>
            <source>Best Pract Res Clin Gastroenterol</source>
            <year>2007</year>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>671</fpage>
            <page-range>671-87</page-range>
            <pub-id pub-id-type="pmid">17643908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sodhi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Camilleri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Camoriano</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Fealey</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome.</article-title>
            <source>Dig Dis Sci</source>
            <year>1989</year>
            <month>Dec</month>
            <volume>34</volume>
            <issue>12</issue>
            <fpage>1937</fpage>
            <page-range>1937-42</page-range>
            <pub-id pub-id-type="pmid">2557192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Selgrad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Giorgio</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cogliandro</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stanghellini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Barbara</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tonini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Corinaldesi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Genta</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Domiati-Saad</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Goel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boland</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Ricciardiello</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction.</article-title>
            <source>Gut</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-32</page-range>
            <pub-id pub-id-type="pmid">18593810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stanghellini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Camilleri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Malagelada</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings.</article-title>
            <source>Gut</source>
            <year>1987</year>
            <month>Jan</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-12</page-range>
            <pub-id pub-id-type="pmid">3817584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jetmore</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Timmcke</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Gathright</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Hicks</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Ray</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Ogilvie's syndrome: colonoscopic decompression and analysis of predisposing factors.</article-title>
            <source>Dis Colon Rectum</source>
            <year>1992</year>
            <month>Dec</month>
            <volume>35</volume>
            <issue>12</issue>
            <fpage>1135</fpage>
            <page-range>1135-42</page-range>
            <pub-id pub-id-type="pmid">1473414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eisen</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Baron</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Dominitz</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Faigel</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Johanson</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Mallery</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Raddawi</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Vargo</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Waring</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Fanelli</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Wheeler-Harbaugh</surname>
                <given-names>J</given-names>
              </name>
              <collab>Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy</collab>
            </person-group>
            <article-title>Acute colonic pseudo-obstruction.</article-title>
            <source>Gastrointest Endosc</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>56</volume>
            <issue>6</issue>
            <fpage>789</fpage>
            <page-range>789-92</page-range>
            <pub-id pub-id-type="pmid">12447286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naveed</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jamil</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Fujii-Lau</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Al-Haddad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Buxbaum</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Fishman</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Jue</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Law</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Qumseya</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Sawhney</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Thosani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Storm</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Calderwood</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Khashab</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wani</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the management of acute colonic pseudo-obstruction and colonic volvulus.</article-title>
            <source>Gastrointest Endosc</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>91</volume>
            <issue>2</issue>
            <fpage>228</fpage>
            <page-range>228-235</page-range>
            <pub-id pub-id-type="pmid">31791596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Giorgio</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Knowles</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Acute colonic pseudo-obstruction.</article-title>
            <source>Br J Surg</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>96</volume>
            <issue>3</issue>
            <fpage>229</fpage>
            <page-range>229-39</page-range>
            <pub-id pub-id-type="pmid">19224517</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Catnach</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Fairclough</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Erythromycin and the gut.</article-title>
            <source>Gut</source>
            <year>1992</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>397</fpage>
            <page-range>397-401</page-range>
            <pub-id pub-id-type="pmid">1568663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Emmanuel</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Shand</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Kamm</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response.</article-title>
            <source>Aliment Pharmacol Ther</source>
            <year>2004</year>
            <month>Mar</month>
            <day>15</day>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>687</fpage>
            <page-range>687-94</page-range>
            <pub-id pub-id-type="pmid">15023171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Nardo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Karunaratne</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Frediani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De Giorgio</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Chronic intestinal pseudo-obstruction: Progress in management?</article-title>
            <source>Neurogastroenterol Motil</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>29</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">29143474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bernardi</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Warrier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Heriot</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Acute and chronic pseudo-obstruction: a current update.</article-title>
            <source>ANZ J Surg</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>85</volume>
            <issue>10</issue>
            <fpage>709</fpage>
            <page-range>709-14</page-range>
            <pub-id pub-id-type="pmid">25943300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mann</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Debinski</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Kamm</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults.</article-title>
            <source>Gut</source>
            <year>1997</year>
            <month>Nov</month>
            <volume>41</volume>
            <issue>5</issue>
            <fpage>675</fpage>
            <page-range>675-81</page-range>
            <pub-id pub-id-type="pmid">9414977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mousa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hyman</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Cocjin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Flores</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Di Lorenzo</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Long-term outcome of congenital intestinal pseudoobstruction.</article-title>
            <source>Dig Dis Sci</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>47</volume>
            <issue>10</issue>
            <fpage>2298</fpage>
            <page-range>2298-305</page-range>
            <pub-id pub-id-type="pmid">12395903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saunders</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Kimmey</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Systematic review: acute colonic pseudo-obstruction.</article-title>
            <source>Aliment Pharmacol Ther</source>
            <year>2005</year>
            <month>Nov</month>
            <day>15</day>
            <volume>22</volume>
            <issue>10</issue>
            <fpage>917</fpage>
            <page-range>917-25</page-range>
            <pub-id pub-id-type="pmid">16268965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23669.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DAVIS</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>LOWMAN</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>An evaluation of cecal size in impending perforation of the cecum.</article-title>
            <source>Surg Gynecol Obstet</source>
            <year>1956</year>
            <month>Dec</month>
            <volume>103</volume>
            <issue>6</issue>
            <fpage>711</fpage>
            <page-range>711-8</page-range>
            <pub-id pub-id-type="pmid">13380697</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
